PHAT vs JNJ: Which Stock is Better?
Side-by-side comparison of Phathom Pharmaceuticals Inc and Johnson & Johnson in 2026
PHAT
Phathom Pharmaceuticals Inc
—
JNJ
Johnson & Johnson
$259.10
Key Metrics Comparison
| Metric | PHAT | JNJ | Winner |
|---|---|---|---|
| Market Cap | $622.74M | $375.37B | JNJ |
| P/E Ratio | N/A | 17.35 | JNJ |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PHAT
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHAT or JNJ a better investment?
Comparing PHAT and JNJ: Phathom Pharmaceuticals Inc has a market cap of $622.74M while Johnson & Johnson has $375.37B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHAT and JNJ?
PHAT (Phathom Pharmaceuticals Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHAT or JNJ?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHAT or JNJ?
Both PHAT and JNJ show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PHAT or JNJ?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PHAT or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $375.37B compared to $622.74M for PHAT.
Should I buy PHAT or JNJ in 2026?
Both PHAT and JNJ have investment merit. PHAT trades at $N/A while JNJ trades at $259.10. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHAT and JNJ stock?
Key differences: Market Cap ($622.74M vs $375.37B), P/E Ratio (N/A vs 17.4x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PHAT or JNJ in 2026?
The choice between PHAT and JNJ depends on your investment goals. JNJ shows higher revenue growth (0.0%). JNJ has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PHAT and JNJ?
PHAT (Phathom Pharmaceuticals Inc) has a market cap of $622.74M, while JNJ (Johnson & Johnson) has a market cap of $375.37B. JNJ is the larger company by market value.